Advancements in CRISPR gene editing offer hope for sickle cell disease treatment

1 min read
Source: STAT
Advancements in CRISPR gene editing offer hope for sickle cell disease treatment
Photo: STAT
TL;DR

CRISPR Therapeutics, along with two other companies, faced the challenge of choosing which genetic disease to target first with the revolutionary gene-editing tool CRISPR-Cas9. After considering various options, they decided to focus on sickle cell disease, making it the first disease to be treated using CRISPR.

Share this article

Want the full story? Read the original reporting

Read on STAT